Status:
COMPLETED
Tegaderm Vs. Transpore for Eye Protection During Anesthesia
Lead Sponsor:
Tufts Medical Center
Conditions:
Eyelid Erythema
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to compare the rate of eyelid erythema after anesthesia with the use of TegadermTM vs. the Transpore®. Our null hypothesis is that the rate of erythema will be similar bet...
Detailed Description
At Tufts Medical Center, a variety of adhesive tapes are used to shut the eyes during anesthesia, including 3MTM TegadermTM and the Sharn Anesthesia Transpore®, with no preference for one or the other...
Eligibility Criteria
Inclusion
- At least 18 years old
- Surgeries scheduled for anesthesia of any duration
Exclusion
- Any patient that does not consent
- Any patient who has:
- Pre-existing eyelid erythema or other eyelid trauma
- Eyelid piercings
- Any surgery on the head, brain, neck, teeth, mouth, eyes, or face
- Surgery in the prone position
- Patients less than 18 years old
Key Trial Info
Start Date :
June 11 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 15 2024
Estimated Enrollment :
165 Patients enrolled
Trial Details
Trial ID
NCT04918290
Start Date
June 11 2021
End Date
May 15 2024
Last Update
October 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tufts Medical Center
Boston, Massachusetts, United States, 02111